{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T07:03:10Z","timestamp":1769497390808,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00381-024-06564-9","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T10:07:19Z","timestamp":1723025239000},"page":"4259-4264","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Carboplatin desensitization in the era of target therapies: still worthwhile?"],"prefix":"10.1007","volume":"40","author":[{"given":"Nat\u00e1lia","family":"Dassi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Sales","family":"da Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Maria","family":"Cappellano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chayanne Andrade","family":"de Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise Neiva Santos","family":"de Aquino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Barbosa","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasjla Saba","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Felipe Chiaverini","family":"Ensina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"6564_CR1","doi-asserted-by":"publisher","first-page":"100857","DOI":"10.1016\/j.neo.2022.100857","volume":"36","author":"N Manoharan","year":"2023","unstructured":"Manoharan N, Liu KX, Mueller S, Haas-Kogan DA, Bandopadhayay P (2023) Pediatric low-grade glioma: targeted therapeutics and clinical trials in the molecular era. Neoplasia 36:100857. https:\/\/doi.org\/10.1016\/j.neo.2022.100857","journal-title":"Neoplasia"},{"issue":"1","key":"6564_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40478-020-00902-z","volume":"8","author":"S Ryall","year":"2020","unstructured":"Ryall S, Tabori U, Hawkins C (2020) Pediatric low-grade glioma in the era of molecular diagnostics. Acta Neuropathol Commun 8(1):30. https:\/\/doi.org\/10.1186\/s40478-020-00902-z","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"6564_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11060-020-03529-1","volume":"150","author":"P de Blank","year":"2020","unstructured":"de Blank P, Fouladi M, Huse JT (2020) Molecular markers and targeted therapy in pediatric low-grade glioma. J Neurooncol 150(1):5\u201315. https:\/\/doi.org\/10.1007\/s11060-020-03529-1","journal-title":"J Neurooncol"},{"issue":"2","key":"6564_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11060-020-03592-8","volume":"149","author":"N Manoharan","year":"2020","unstructured":"Manoharan N, Choi J, Chordas C, Zimmerman MA, Scully J, Clymer J, Filbin M, Ullrich NJ, Bandopadhayay P, Chi SN, Yeo KK (2020) Trametinib for the treatment of recurrent\/progressive pediatric low-grade glioma. J Neurooncol 149(2):253\u2013262. https:\/\/doi.org\/10.1007\/s11060-020-03592-8","journal-title":"J Neurooncol"},{"issue":"3","key":"6564_CR5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11060-020-03640-3","volume":"149","author":"F Selt","year":"2020","unstructured":"Selt F, van Tilburg CM, Bison B, Sievers P, Harting I, Ecker J, Pajtler KW, Sahm F, Bahr A, Simon M, Jones DTW, Well L, Mautner VF, Capper D, Hern\u00e1iz Driever P, Gnekow A, Pfister SM, Witt O, Milde T (2020) Response to trametinib treatment in progressive pediatric low-grade glioma patients. J Neurooncol 149(3):499\u2013510. https:\/\/doi.org\/10.1007\/s11060-020-03640-3","journal-title":"J Neurooncol"},{"issue":"5","key":"6564_CR6","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1200\/JCO.1993.11.5.850","volume":"11","author":"RJ Packer","year":"1993","unstructured":"Packer RJ, Lange B, Ater J, Nicholson HS, Allen J, Walker R, Prados M, Jakacki R, Reaman G, Needles MN et al (1993) Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 11(5):850\u2013856. https:\/\/doi.org\/10.1200\/JCO.1993.11.5.850","journal-title":"J Clin Oncol"},{"issue":"1","key":"6564_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mpo.1154","volume":"37","author":"Y Tsuchida","year":"2001","unstructured":"Tsuchida Y, Therasse P (2001) Response evaluation criteria in solid tumors (RECIST): new guidelines. Med Pediatr Oncol 37(1):1\u20133. https:\/\/doi.org\/10.1002\/mpo.1154","journal-title":"Med Pediatr Oncol"},{"issue":"371","key":"6564_CR8","first-page":"376","volume":"114","author":"SGA Brown","year":"2004","unstructured":"Brown SGA (2004) Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 114(371):376","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"6564_CR9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.iac.2017.06.003","volume":"37","author":"IM Otani","year":"2017","unstructured":"Otani IM, Wong J, Banerji A (2017) Platinum chemotherapy hypersensitivity. Immunol Allergy Clin North Am 37(4):663\u2013677","journal-title":"Immunol Allergy Clin North Am"},{"issue":"2","key":"6564_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s11060-014-1652-6","volume":"121","author":"AM Cappellano","year":"2015","unstructured":"Cappellano AM, Petrilli AS, da Silva NS, Silva FA, Paiva PM, Cavalheiro S, Bouffet E (2015) Single agent vinorelbine in pediatric patients with progressive optic pathway glioma. J Neurooncol 121(2):405\u2013412. https:\/\/doi.org\/10.1007\/s11060-014-1652-6","journal-title":"J Neurooncol"},{"key":"6564_CR11","doi-asserted-by":"publisher","unstructured":"Dassi N, Silva NS, Silva FA, Almeida DB, Oliveira MR, Cavalheiro S, Dastoli PA, Seixas MT, Cappellano AM (2021) Single-agent oral vinorelbine in the treatment of pediatric progressive optic pathway glioma: a single institutional experience. Clin Oncol Res 2613\u20134942 https:\/\/doi.org\/10.31487\/j.COR.2021.07.05","DOI":"10.31487\/j.COR.2021.07.05"},{"issue":"29","key":"6564_CR12","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1200\/JCO.2016.68.1585","volume":"34","author":"A Lassaletta","year":"2016","unstructured":"Lassaletta A, Scheinemann K, Zelcer SM, Hukin J, Wilson BA, Jabado N, Carret AS, Lafay-Cousin L, Larouche V, Hawkins CE, Pond GR, Poskitt K, Keene D, Johnston DL, Eisenstat DD, Krishnatry R, Mistry M, Arnoldo A, Ramaswamy V, Huang A, Bartels U, Tabori U, Bouffet E (2016) Phase II weekly vinblastine for chemotherapy-na\u00efve children with progressive low-grade glioma: a Canadian Pediatric Brain Tumor Consortium Study. J Clin Oncol 34(29):3537\u20133543. https:\/\/doi.org\/10.1200\/JCO.2016.68.1585","journal-title":"J Clin Oncol"},{"key":"6564_CR13","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ygyno.2004.08.002","volume":"95","author":"CW Lee","year":"2004","unstructured":"Lee CW, Matulonis UA, Castells MC (2004) Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell\/IgE-mediated reactions. Gynecol Oncol 95:370\u2013376","journal-title":"Gynecol Oncol"},{"issue":"8","key":"6564_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fphar.2017.00179","volume":"7","author":"A Ruggiero","year":"2017","unstructured":"Ruggiero A, Rizzo D, Catalano M, Maurizi P, Mastrangelo S, Attin\u00e0 G, Riccardi R (2017) Rechallenge to carboplatin in children with low grade glioma and carboplatin hypersensitivity reactions. Front Pharmacol 7(8):179. https:\/\/doi.org\/10.3389\/fphar.2017.00179","journal-title":"Front Pharmacol"},{"key":"6564_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00520-011-1123-y","volume":"20","author":"DB Genc","year":"2012","unstructured":"Genc DB, Canpolat C, Berrak SG (2012) Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low-grade glioma. Support Care Cancer 20:385\u2013393","journal-title":"Support Care Cancer"},{"key":"6564_CR16","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/cncr.23249","volume":"112","author":"L Lafay-Cousin","year":"2008","unstructured":"Lafay-Cousin L, Sung L, Carret AS, Hukin J, Wilson B, Johnston DL, Zelcer S, Silva M, Odame I, Mpofu C, Strother D, Bouffet E (2008) Carboplatin hypersensitivity reaction in pediatric patients with low-grade glioma: a Canadian Pediatric Brain Tumor Consortium experience. Cancer 112:892\u2013899","journal-title":"Cancer"},{"key":"6564_CR17","first-page":"1","volume":"9999","author":"AC Shah","year":"2015","unstructured":"Shah AC, Minturn JE, Li Y, Belasco JB, Phillips PC, Kang TI, Cole KA, Waanders AJ, Pollack R, Didomenico C, Wildes C, Fisher MJ (2015) Carboplatin rechallenge after hypersensitivity reactions in pediatric patients with low-grade glioma. Pediatr Blood Cancer 9999:1\u20136","journal-title":"Pediatr Blood Cancer"},{"key":"6564_CR18","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/neuonc\/nos202","volume":"14","author":"AK Gnekow","year":"2012","unstructured":"Gnekow AK, Falkenstein F, von Hornstein S, Zwiener I, Berkefeld S, Bison B, Warmuth-Metz M, Driever PH, Soerensen N, Kortmann RD, Pietsch T, Faldum A (2012) Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology. Neuro Oncol 14:1265\u20131284","journal-title":"Neuro Oncol"},{"issue":"3","key":"6564_CR19","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jaci.2008.02.044","volume":"122","author":"MC Castells","year":"2008","unstructured":"Castells MC, Tennant NM, Sloane DE, Hsu FI, Barrett NA, Hong DI et al (2008) Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol 122(3):574\u2013580","journal-title":"J Allergy Clin Immunol"},{"key":"6564_CR20","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jaip.2018.09.008","volume":"7","author":"E Macy","year":"2019","unstructured":"Macy E, Ensina LF (2019) Controversies in allergy: is skin testing required prior to drug challenges? J Allergy Clin Immunol Pract 7:412\u2013417","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"6564_CR21","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.anai.2015.07.017","volume":"115","author":"AL Wang","year":"2015","unstructured":"Wang AL, Patil SU, Long AA, Banerji A (2015) Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy. Ann Allergy Asthma Immunol 115(5):422\u2013428","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"6564_CR22","first-page":"1668","volume":"8","author":"J Silver","year":"2020","unstructured":"Silver J, Garcia-Neuer M, Lynch D-M, Pasaoglu G, Sloane DE, Castells M (2020) Endophenotyping oxaliplatin hypersensitivity: personalizing desensitization to the atypical platin. J Allergy Clin Immunol: In Practice 8(5):1668-1680.e2","journal-title":"J Allergy Clin Immunol: In Practice"},{"issue":"4","key":"6564_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/ACI.0000000000000381","volume":"17","author":"JR Cernadas","year":"2017","unstructured":"Cernadas JR (2017) Reactions to cytostatic agents in children. Curr Opin Allergy Clin Immunol 17(4):255\u2013261","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"6564_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/pbc.22917","volume":"57","author":"K Scheinemann","year":"2011","unstructured":"Scheinemann K, Bartels U, Tsangaris E, Hawkins C, Huang A, Dirks P, Fried I, Bouffet E, Tabori U (2011) Feasibility and efficacy of repeated chemotherapy for progressive pediatric low-grade gliomas. Pediatr Blood Cancer 57(1):84\u201388. https:\/\/doi.org\/10.1002\/pbc.22917","journal-title":"Pediatr Blood Cancer"},{"key":"6564_CR25","doi-asserted-by":"publisher","first-page":"e2200156","DOI":"10.1200\/GO.22.00156","volume":"8","author":"S Bailey","year":"2022","unstructured":"Bailey S, Davidson A, Parkes J, Tabori U, Figaji A, Epari S, Chinnaswamy G, Dias-Coronado R, Casavilca-Zambrano S, Amayiri N, Vassal G, Bouffet E, Clifford SC (2022) How can genomic innovations in pediatric brain tumors transform outcomes in low- and middle-income countries? JCO Glob Oncol 8:e2200156. https:\/\/doi.org\/10.1200\/GO.22.00156","journal-title":"JCO Glob Oncol"},{"key":"6564_CR26","doi-asserted-by":"publisher","first-page":"e2300017","DOI":"10.1200\/GO.23.00017","volume":"9","author":"DC Moreira","year":"2023","unstructured":"Moreira DC, Lam CG, Bhakta N, Boop FA, Chiang J, Merchant TE, Rodriguez-Galindo C, Gajjar A, Qaddoumi I (2023Apr) Tackling pediatric low-grade gliomas: a global perspective. JCO Glob Oncol 9:e2300017. https:\/\/doi.org\/10.1200\/GO.23.00017","journal-title":"JCO Glob Oncol"},{"issue":"6","key":"6564_CR27","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1111\/pai.13525","volume":"32","author":"J Cernadas","year":"2021","unstructured":"Cernadas J, Vasconcelos MJ, Fernandes AP, Carneiro-Le\u00e3o L, Gil-da-Costa MJ (2021) Desensitization to carboplatin in low-grade glioma. A revision of 100 treatments in children. Pediatr Allergy Immunol 32(6):1388\u20131391. https:\/\/doi.org\/10.1111\/pai.13525","journal-title":"Pediatr Allergy Immunol"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-024-06564-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-024-06564-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-024-06564-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T09:46:49Z","timestamp":1732096009000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-024-06564-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["6564"],"URL":"https:\/\/doi.org\/10.1007\/s00381-024-06564-9","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]},"assertion":[{"value":"27 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the hospital\u2019s Research Ethics Board IOP-GRAACC and UNIFESP (Federal University of Sao Paulo).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The study was approved by the hospital\u2019s Research Ethics Board IOP-GRAACC and UNIFESP (Federal University of Sao Paulo).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}